View Past PerformanceProactis バランスシートの健全性財務の健全性 基準チェック /06Proactisの健全性を判断するにはデータが不十分です主要情報n/a負債資本比率n/a負債インタレスト・カバレッジ・レシオn/a現金n/aエクイティn/a負債合計n/a総資産n/a財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 04Proactis SA Announces Board ChangesUnder the terms of the Board of Directors of the company PROACTIS SA held on the 14April 2026, Mrs. Rebecca ARCHER has been appointed as Director in replacement of Mrs. Charlotte CARTER, resigning. Rebecca Archer joined Proactis in 2025. She is a Chartered Accountant and has a degree in Physics from the University of Oxford. She qualified at Deloitte where she spent six years including three years in New Zealand and has over 20 years of experience working in a variety of organizations including RM plc and Namene Solar. Rebecca was Group Finance Director at Science Group plc which was highly acquisitive where she led the business integrations and brings a wealth of business transformation experience to Proactis. During this same meeting, Mr. Phil DENNANT has been appointed as Director in replacement of Mr. Peter SHEPHERD, resigning. Mr. Philip Dennant joined Proactis in 2021. He currently holds the position of Director of FP&A, responsible for financial planning and strategic analysis to support executive decision-making and long-term business growth. Prior to this, he spent nearly a decade working within large UK-listed companies. Shareholders will be asked to approve these appointments at the next Annual General Meeting called to approve the financial statements for the year ended January 31, 2026. As a result of these changes, the Board of Directors of PROACTIS SA is now composed as follows: Andrew REARDON serves as Chairman of the Board of Directors and Chief Executive Officer, with his mandate expiring at the Annual General Meeting to approve the financial statements for the year ending January 31, 2028. Rebecca ARCHER holds the position of Director, and her mandate will expire at the Annual General Meeting to approve the financial statements for the year ending January 31, 2030. Phil DENNANT is also a Director, with his mandate expiring at the Annual General Meeting to approve the financial statements for the year ending January 31, 2028. Maria LARSEN serves as Director, and her mandate will expire at the Annual General Meeting to approve the financial statements for the year ending January 31, 2028.New Risk • Apr 29New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended January 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported January 2024 fiscal period end). Share price has been highly volatile over the past 3 months (37% average weekly change). Market cap is less than US$10m (€5.42m market cap, or US$6.33m).New Risk • Apr 19New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shares are highly illiquid. Market cap is less than US$10m (€5.96m market cap, or US$7.01m).Board Change • Mar 10No independent directorsThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). CEO & Chairman of the Board Andrew Reardon is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.財務状況分析短期負債: HUOの 短期資産 が 短期負債 をカバーしているかどうかを判断するにはデータが不十分です。長期負債: HUOの短期資産が 長期負債 をカバーしているかどうかを判断するにはデータが不十分です。デット・ツー・エクイティの歴史と分析負債レベル: HUOの 純負債対資本比率 を計算して 満足できる ものであるかどうかを判断するにはデータが不十分です。負債の削減: HUOの負債対資本比率が過去 5 年間で減少したかどうかを判断するにはデータが不十分です。債務返済能力: HUOの負債が 営業キャッシュフロー によって 十分にカバーされている かどうかを判断するにはデータが不十分です。インタレストカバレッジ: HUOの負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YSoftware 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/07 14:16終値2026/07/07 00:00収益2024/01/31年間収益2024/01/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Proactis SA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 04Proactis SA Announces Board ChangesUnder the terms of the Board of Directors of the company PROACTIS SA held on the 14April 2026, Mrs. Rebecca ARCHER has been appointed as Director in replacement of Mrs. Charlotte CARTER, resigning. Rebecca Archer joined Proactis in 2025. She is a Chartered Accountant and has a degree in Physics from the University of Oxford. She qualified at Deloitte where she spent six years including three years in New Zealand and has over 20 years of experience working in a variety of organizations including RM plc and Namene Solar. Rebecca was Group Finance Director at Science Group plc which was highly acquisitive where she led the business integrations and brings a wealth of business transformation experience to Proactis. During this same meeting, Mr. Phil DENNANT has been appointed as Director in replacement of Mr. Peter SHEPHERD, resigning. Mr. Philip Dennant joined Proactis in 2021. He currently holds the position of Director of FP&A, responsible for financial planning and strategic analysis to support executive decision-making and long-term business growth. Prior to this, he spent nearly a decade working within large UK-listed companies. Shareholders will be asked to approve these appointments at the next Annual General Meeting called to approve the financial statements for the year ended January 31, 2026. As a result of these changes, the Board of Directors of PROACTIS SA is now composed as follows: Andrew REARDON serves as Chairman of the Board of Directors and Chief Executive Officer, with his mandate expiring at the Annual General Meeting to approve the financial statements for the year ending January 31, 2028. Rebecca ARCHER holds the position of Director, and her mandate will expire at the Annual General Meeting to approve the financial statements for the year ending January 31, 2030. Phil DENNANT is also a Director, with his mandate expiring at the Annual General Meeting to approve the financial statements for the year ending January 31, 2028. Maria LARSEN serves as Director, and her mandate will expire at the Annual General Meeting to approve the financial statements for the year ending January 31, 2028.
New Risk • Apr 29New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended January 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported January 2024 fiscal period end). Share price has been highly volatile over the past 3 months (37% average weekly change). Market cap is less than US$10m (€5.42m market cap, or US$6.33m).
New Risk • Apr 19New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shares are highly illiquid. Market cap is less than US$10m (€5.96m market cap, or US$7.01m).
Board Change • Mar 10No independent directorsThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). CEO & Chairman of the Board Andrew Reardon is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.